ARMPNYSEBiological Products, (No Diagnostic Substances)

Armata Pharmaceuticals, Inc. (ARMP) earnings date, market-implied expected move, and options open interest by expiry

3.19

−0.06 · −1.87%

post 3.25 +1.85%

Closed15:59 ET

Open3.25Volume46,741Mkt cap$122.0M

Day3.25 – 3.255%52-wk2.75 – 14.984%

ARMP

Armata Pharmaceuticals, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 11

after close · in 11 days

est.Q3 FY26

Calendar

Next report

Last report

+11.83%

vs ±55.9% implied · ×0.21

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+39.24%

shares held · 10 largest managers

13F · Jun 30 '26123d lag

53 managers

Top fund weight

0.00%

ARMP weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Armata Pharmaceuticals (ARMP) is expected to report on Nov 11 after close (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 12 '26confirmed±55.9%▲+11.83%×0.21

quarterimplied−60%0+60%realized×

Q2 FY26±55.9%▲+11.83%×0.21

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Aug 28 close

3.06OI · 2 expiries · Aug 28 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

49—Nov 2020d16+129%

0—Feb 19111d0.0026+30%0.00

ExpiryPutsCallsP/C

Nov 2020d49—16+129%3.06

Feb 19111d0—26+30%0.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

2953.82%as filednet margin · revenue +218.12% QoQ · +15.72% YoY

Revenue$3M+218.12%

Gross profit$3M100.00%+218.12%

Operating income−$10M−410.84%−17.38%

Pre-tax income$74M+164.28%

Net income$74M2953.82%+164.28%

Cost of revenue$0—

Operating expenses$13M+33.93%

Other income$84M+179.25%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

PPI ×1.30· ±5.9% vs ±4.5% · 11 releases

eventrelease day|move|up · n×base

PPIproducer prices±5.9%5 of 11×1.30

NFPjobs report±4.7%4 of 10×1.04

FOMCrate decision±4.2%7 of 24×0.94

PCEpersonal income & outlays±4.0%10 of 19×0.89

CPROFcorporate profits±3.6%5 of 12×0.81

CPIconsumer prices±3.5%3 of 11×0.78

GDPgross domestic product±3.2%10 of 19×0.71

Bar = avg |move| to ±6% · tick = ±4.5% avg day · ×base = |move| ÷ ±4.5% · min 6 releases

Earnings history

EPS -0.27 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	-0.27	—
Q1 FY26	—	-3.16	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod